0001127602-16-053377.txt : 20160525
0001127602-16-053377.hdr.sgml : 20160525
20160525152908
ACCESSION NUMBER: 0001127602-16-053377
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160523
FILED AS OF DATE: 20160525
DATE AS OF CHANGE: 20160525
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sheridan William P
CENTRAL INDEX KEY: 0001439174
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 161674533
MAIL ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2016-05-23
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001439174
Sheridan William P
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Senior VP - CMO
Emp. Stock Option (Right to Buy)
3.22
2016-05-23
4
A
0
148302
0
A
2017-05-23
2026-05-23
Common Stock
148302
148302
D
Retention Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.
/s/ Alane P. Barnes, by power of attorney
2016-05-25